La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Auteurs » - entrée « Pierre J. Blanchet »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pierre Hellier < Pierre J. Blanchet < Pierre J. Talbot  Facettes :

List of bibliographic references indexed by Pierre J. Blanchet

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000683 (2015) Pierre J. Blanchet [Canada] ; Emmanuelle PourcherIn memoriam: Paul J. Bédard, MD PhD: January 19, 1942-December 26, 2014.
001267 (2012) Pierre J. Blanchet [Canada] ; Louise Normandeau ; Pierre H. RompréComparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot study.
001541 (2012) Pierre J. Blanchet [Canada] ; Louise Normandeau [Canada] ; Pierre H. Rompre [Canada]Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: A pilot study
001A13 (2010) Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard ; Dominic Langlois ; Pierre J. Blanchet ; Martin Lemay ; Maxime ParentMovement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson's disease.
001C90 (2010) Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard [Canada] ; Dominic Langlois [Canada] ; Pierre J. Blanchet [Canada] ; Martin Lemay [Canada] ; Maxime Parent [Canada]Movement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson's disease
002078 (2009) Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard [Canada] ; Maxime Levesque [Canada] ; Mark Chebli [Canada] ; Maxime Parent [Canada] ; Richard Courtemanche [Canada] ; Pierre J. Blanchet [Canada]Motor sequence learning in primate : Role of the D2 receptor in movement chunking during consolidation
002231 (2008) Abdesslem Khiat [Canada] ; Yevgeniy Kuznetsov [Canada] ; Pierre J. Blanchet [Canada] ; Yvan Boulanger [Canada]Diffusion‐weighted imaging and magnetization transfer imaging of tardive and edentulous orodyskinesia
002386 (2008) Anne Beuter [France] ; Roberto Hernandez [Canada] ; Robert Rigal [Canada] ; Julien Modolo [France] ; Pierre J. Blanchet [Canada]Postural Sway and Effect of Levodopa in Early Parkinson's Disease
002B41 (2005) Anne Beuter [France] ; Emilie Barbo [Canada] ; Robert Rigal [Canada] ; Pierre J. Blanchet [Canada]Characterization of subclinical tremor in Parkinson's disease
002D65 (2003) Pepijn Van Den Munckhof [Canada] ; Kelvin C. Luk ; Line Ste-Marie ; Jane Montgomery ; Pierre J. Blanchet ; Abbas F. Sadikot ; Jacques DrouinPitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons.
002E98 (2003) Pierre J. Blanchet [Canada]The fluctuating Parkinsonian patient: Clinical and pathophysiological aspects
002F05 (2003) Pierre J. Blanchet [États-Unis, Canada] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis]Renaissance of amantadine in the treatment of Parkinson's disease
002F44 (2003) Pierre J. Blanchet [États-Unis, Canada] ; Spiros Konitsiotis [États-Unis, Grèce] ; Hideki Mochizuki [États-Unis, Japon] ; Ryszard Pluta [États-Unis] ; Dwaine F. Emerich [États-Unis] ; Thomas N. Chase [États-Unis] ; M. Maral Mouradian [États-Unis]Complications of a trophic xenotransplant approach in parkinsonian monkeys
003103 (2002) Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Othman Ghribi [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]Alteration of glutamate receptors in the striatum of dyskinetic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment
003237 (2001) Frédéric Calon [Canada] ; Nadia Lavertu [Canada] ; Anne-Marie Lemieux [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of MPTP‐induced denervation on basal ganglia GABAB receptors: Correlation with dopamine concentrations and dopamine transporter
003289 (2001) Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Daniel Levesque [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model
003512 (2000) Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Pierre J. Blanchet [Canada] ; Marc Morissette [Canada] ; Richard Grondin [Canada] ; Martin Goulet [Canada] ; Jean-Pierre Doucet [Canada] ; George S. Robertson [Canada] ; Eric Nestler [États-Unis] ; Thérèse Di Paolo [Canada] ; Paul J. Bédard [Canada]Dopamine-receptor stimulation: biobehavioral and biochemical consequences
003545 (2000) Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Pierre J. Blanchet ; Paul J. Bédard ; Thérèse Di Paolo125I-CGP 64213 Binding to GABAB Receptors in the Brain of Monkeys: Effect of MPTP and Dopaminomimetic Treatments
003681 (1999) Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Pierre J. Blanchet ; Paul J. Bédard ; Thérèse Di Paolo [Canada]Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABAA/benzodiazepine receptor complex and GABA content
003A98 (1997) Marc Morissette [Canada] ; Martin Goulet [Canada] ; Jean-Jacques Soghomonian [Canada] ; Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with l-DOPA therapy
003D21 (1996) Jean-Jacques Soghomonian [Canada] ; Sophie Pedneault [Canada] ; Pierre J. Blanchet [Canada] ; Martin Goulet [Canada] ; Thérèse Di Paolo [Canada] ; Paul J. Bédard [Canada]l-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Pierre J. Blanchet" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Pierre J. Blanchet" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Pierre J. Blanchet
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022